HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoji Ishizu Selected Research

Albumins

8/2021Transient deterioration of albumin-bilirubin scores in early post-dose period of molecular targeted therapies in advanced hepatocellular carcinoma with 50% or higher liver occupation: A STROBE-compliant retrospective observational study.
3/2021The relationship between oral-origin bacteria in the fecal microbiome and albumin-bilirubin grade in patients with hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoji Ishizu Research Topics

Disease

26Hepatocellular Carcinoma (Hepatoma)
04/2022 - 01/2015
14Neoplasms (Cancer)
11/2021 - 12/2014
12Fibrosis (Cirrhosis)
04/2022 - 06/2012
10Chronic Hepatitis C
12/2021 - 04/2010
9Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 06/2012
8Inflammation (Inflammations)
04/2022 - 01/2016
7Infections
01/2021 - 08/2016
6Hepatitis C
03/2021 - 08/2016
5Non-alcoholic Fatty Liver Disease
04/2022 - 09/2015
5Hemorrhage
10/2021 - 02/2019
5Hepatitis B
01/2021 - 10/2013
4Liver Diseases (Liver Disease)
01/2022 - 03/2019
4Hepatitis
01/2021 - 01/2016
3Hepatic Encephalopathy
03/2022 - 03/2019
3Alcoholic Fatty Liver
11/2021 - 09/2017
3Disease Progression
10/2021 - 05/2016
3Fever (Fevers)
06/2020 - 01/2016
3Thrombosis (Thrombus)
04/2020 - 01/2016
2Varicose Veins (Varicose Vein)
12/2022 - 10/2021
2Diarrhea
03/2022 - 02/2020
2Hemophilia A (Haemophilia)
01/2022 - 01/2021
2Chronic Hepatitis B
01/2021 - 01/2015
2Hypersplenism (Anemia, Splenic)
01/2020 - 01/2013
2Autoimmune Hepatitis
05/2016 - 01/2016
2Autoimmune Pancreatitis
05/2016 - 01/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022
1Portal Hypertension
10/2021
1Obesity
01/2021
1Vitelliform Macular Dystrophy
04/2020
1Hand-Foot Syndrome
02/2020
1Virus Diseases (Viral Diseases)
01/2020
1Insulin Resistance
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Obstructive Jaundice (Cholestatic Jaundice)
01/2020
1Hypersensitivity (Allergy)
10/2019
1Drug Hypersensitivity (Drug Allergy)
10/2019

Drug/Important Bio-Agent (IBA)

11Antiviral Agents (Antivirals)IBA
01/2022 - 08/2016
10Sorafenib (BAY 43-9006)FDA Link
06/2020 - 01/2015
6Choline (Choline Chloride)IBA
04/2022 - 09/2015
5lenvatinibIBA
03/2022 - 03/2020
4BilirubinIBA
08/2021 - 02/2018
4InterferonsIBA
02/2018 - 06/2012
4Ribavirin (Virazole)FDA LinkGeneric
02/2018 - 04/2010
4daclatasvirIBA
01/2018 - 08/2016
4asunaprevirIBA
01/2018 - 08/2016
3Immune Checkpoint InhibitorsIBA
02/2022 - 06/2020
3Therapeutic UsesIBA
11/2021 - 01/2019
3Pemetrexed (MTA)FDA Link
08/2021 - 03/2021
3Branched-Chain Amino AcidsIBA
01/2020 - 01/2017
3regorafenibIBA
10/2019 - 01/2018
3Immunoglobulins (Immunoglobulin)IBA
05/2016 - 10/2014
2Estrogens (Estrogen)FDA Link
04/2022 - 09/2015
2Amino AcidsFDA Link
01/2022 - 01/2021
2AlbuminsIBA
08/2021 - 03/2021
2Carbon Tetrachloride (Tetrachloromethane)IBA
01/2021 - 09/2017
2Hepatitis B e AntigensIBA
01/2021 - 01/2015
2Cytidine Triphosphate (CTP)IBA
09/2020 - 07/2020
2RamucirumabIBA
04/2020 - 09/2019
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2020 - 01/2015
2telomerase RNA (bTR)IBA
01/2020 - 01/2020
2ZincIBA
01/2020 - 01/2020
2Tyrosine (L-Tyrosine)FDA Link
01/2020 - 01/2020
2Pharmaceutical PreparationsIBA
10/2019 - 12/2014
2Serum AlbuminIBA
02/2018 - 01/2018
2gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
02/2018 - 01/2018
2AntigensIBA
02/2018 - 10/2013
2Proteins (Proteins, Gene)FDA Link
09/2017 - 10/2014
2Hepatitis B Surface Antigens (HBsAg)FDA Link
11/2016 - 01/2015
2Immunoglobulin G (IgG)IBA
05/2016 - 01/2016
1Sclerosing Solutions (Sclerosing Agents)IBA
12/2022
1astaxanthine (astaxanthin)IBA
04/2022
1OsteoprotegerinIBA
04/2022
1Butyrates (Butyrate)IBA
03/2022
1Rifaximin (L 105)FDA Link
03/2022
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
11/2021
1EmulsionsIBA
11/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2021
1Conditioned Culture MediaIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1Isoleucine (L-Isoleucine)FDA Link
01/2021
1Leucine (L-Leucine)FDA Link
01/2021
1Blood Coagulation Factors (Coagulation Factor)IBA
01/2021
1CTLA-4 AntigenIBA
06/2020
1IpilimumabIBA
06/2020
1Volatile Fatty AcidsIBA
02/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Thrombopoietin (c-mpl Ligand)IBA
01/2020
1Hyaluronic Acid (Hyaluronan)IBA
01/2020
1Tyrosine Kinase InhibitorsIBA
10/2019
1Vitamin K 2 (Vitamin K2)IBA
03/2019

Therapy/Procedure

19Therapeutics
12/2022 - 04/2010
8Liver Transplantation
01/2021 - 01/2013
3Ligation
10/2021 - 01/2016
1Sclerotherapy
12/2022
1Time-to-Treatment
01/2022
1Molecular Targeted Therapy
08/2021
1Aftercare (After-Treatment)
03/2021
1Surgical Portasystemic Shunt (Portosystemic Shunt)
03/2021
1Intravenous Administration
01/2021
1Radiofrequency Ablation
01/2021